The aim of the work was to evaluate the plasma level of adiponectin and its correlation with CIMT in Egyptian patients with NAFLD and to study the effects of obesity and T2DM on the correlation between CIMT and adiponectin. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.